Top in ID: Contact tracing, remdesivir and COVID-19

Recent survey results show that less than half of patients with confirmed SARS-CoV-2 infection reported being in contact with someone infected. This was the top story in infectious disease last week.

Another top story was about an announcement from Gilead Sciences that the company will be making remdesivir available to governments of developed countries for the treatment of COVID-19.

Read these and more top stories in infectious disease below:

Less than half of COVID-19 patients report recent contact with infected person

Less than half of inpatients and outpatients with confirmed SARS-CoV-2 infection reported recent contact with an infected person, according to survey results published in MMWR. Read more.

US, Gilead strike deal for large supply of remdesivir for COVID-19

Gilead Sciences recently announced that remdesivir — one of the only recommended treatments for COVID-19 — will be available to governments of developed countries for $390 per vial. Read more.

Rat-bite fever more prominent in children, young adults

Rat-bite fever occurs rarely in the United States but is more prominent in children compared with other populations when it does occur, according to findings published in in Open Forum Infectious Diseases. Read more.

T2 Biosystems announces launch of COVID-19 diagnostic test

T2 Biosystems, Inc. announced the launch of T2SARS-CoV-2 Panel, a COVID-19 molecular diagnostic test, according to a press release issued by the company. Read more.

Serial COVID-19 testing detects asymptomatic, presymptomatic infections in Louisiana jail

Testing of quarantined inmates and detainees in a Louisiana facility identified “a high proportion” of asymptomatic and pre-symptomatic persons who likely would have been missed through symptom screening only, according to findings in MMWR. Read more.